Skip to main content
. 2017 Jan 19;49(4):1044–1056. doi: 10.4143/crt.2016.515

Table 3.

Associations of interleukin genetic polymorphisms (dominant model) with gastric cancer risk

Gene rs No. No. (%)
OR (95% CI)
Control Case Control Fully adjusteda)
IL10 rs1800871 AA 368 (48.81) 173 (45.89) 1 1
G+ 386 (51.19) 204 (54.11) 1.12 (0.88-1.44) 1.06 (0.80-1.41)
IL2 rs2069763 AA 226 (29.97) 1111 (29.44) 1 1
C+ 528 (70.03) 266 (70.56) 1.03 (0.78-1.35) 1.19 (0.88-1.62)
rs2069762 AA 358 (47.73) 165 (43.77) 1 1
C+ 392 (52.27) 212 (56.23) 1.17 (0.92-1.51) 1.23 (0.93-1.64)
IL13 rs6596090 GG 517 (70.24) 255 (69.29) 1 1
A+ 219 (29.76) 113 (30.71) 1.05 (0.80-1.37) 1.04 (0.77-1.43)
rs20541 GG 366 (48.54) 185 (49.07) 1 1
A+ 388 (51.46) 192 (50.93) 0.98 (0.76-1.25) 0.86 (0.65-1.14)
IL4R rs7205663 TT 259 (34.35) 126 (33.42) 1 1
C+ 495 (65.65) 251 (66.58) 1.04 (0.80-1.35) 0.99 (0.73-1.33)
rs1805010 GG 253 (33.55) 126 (33.42) 1 1
A+ 501 (66.45) 251 (66.58) 1.01 (0.77-1.31) 0.95 (0.70-1.28)

OR, odds ratio; CI, confidence interval.

a)

Adjusted by education, alcohol consumption, smoking status, Helicobacter pylori infection, and regular exercise.